MMDS Medical
- Gérant
maintenant
Mathieu Maassen earned an MBA from HEC Montréal, a M.Sc. in Business Administration (ESCP, Paris) and a degree in accounting. This background allows him to cover all aspects of corporate management, both in a European and North American context.
Since 2004, Mathieu Maassen is a consultant active in strategic consulting for clients specialized in innovative medical technologies. Both institutions and companies. For institutions he has worked on various projects in valorization in Montreal surroundings, in particular the issues of valorization of medical research and its financing. He also accompanies various companies and projects in medical technologies or biotechnologies.
Prior to that, he accumulated 12 years of experience as a manager of hospitals and institutions for the disabled persons. In that capacity, he has initiated and managed several missions of merger - acquisitions, reorganization and reconstruction of Health Care organizations and establishments.
After managing a company in the field of high performance materials (where he was more particularly in charge of finance, international development and industrial reorganization), he crated a consulting firm specialized in strategic consulting for technology companies.
His mandates in that capacity included, among others, the creation of structures for the valorization of medical research (Institute Pasteur, Academic Hospitals of Lille, EuraSanté Parc in Lille, Faculty of Pharmacy in Lyon, France), reorganization of laboratories, and clinical services,
At last, Mathieu was in charge of a distribution network covering 35 countries worldwide for an innovative company in the field of surgical implants and related simulation software.
His career and experience allow Mathieu to have a comprehensive view of issues related with applied research, clinical research, promotion and marketing of medical technologies, as well as their introduction in clinical settings.
Specialties:
Strategic consulting and general management in life sciences, both for the medical device industry and health care institutions.
